Health
Vaccine experts meeting over clot report – The Islander
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General20 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General9 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging